Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm

Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm

Background: Hypertension (HTN) is the most frequent adverse event during treatment with lenvatinib (LEN), but data on its best management are limited. Aim: The objective of this study was to assess incidence, features and best management of LEN-related HTN in a consecutive single tertiary-care cen...

Full description

Bibliographic Details
Main Authors: Carla Colombo, Daniele Ceruti, Simone De Leo, Grzegorz Bilo, Matteo Trevisan, Noemi Giancola, Claudia Moneta, Gianfranco Parati, Luca Persani, Laura Fugazzola
Format: Article
Language:English
Published: Bioscientifica 2023-06-01
Series:European Thyroid Journal
Subjects:
thyroid cancer
lenvatinib
hypertension
adverse event
treatment
Online Access:https://etj.bioscientifica.com/view/journals/etj/12/4/ETJ-23-0047.xml

Internet

https://etj.bioscientifica.com/view/journals/etj/12/4/ETJ-23-0047.xml

Similar Items